DK335686A - Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden Download PDF

Info

Publication number
DK335686A
DK335686A DK335686A DK335686A DK335686A DK 335686 A DK335686 A DK 335686A DK 335686 A DK335686 A DK 335686A DK 335686 A DK335686 A DK 335686A DK 335686 A DK335686 A DK 335686A
Authority
DK
Denmark
Prior art keywords
procedure
carba
cephem
intermediates
derivatives
Prior art date
Application number
DK335686A
Other languages
English (en)
Other versions
DK173456B1 (da
DK335686D0 (da
Inventor
David Albert Evans
Eric Brian Sjogren
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DK335686D0 publication Critical patent/DK335686D0/da
Publication of DK335686A publication Critical patent/DK335686A/da
Application granted granted Critical
Publication of DK173456B1 publication Critical patent/DK173456B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198603356A 1985-07-17 1986-07-15 Fremgangsmåde til fremstilling af cis-enantiomere af 1-carba-3-cephem-4-carboxylsyrer og derivater deraf samt forskellige 3 DK173456B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/755,982 US4665171A (en) 1985-07-17 1985-07-17 Process and intermediates for β-lactam antibiotics
US75598285 1985-07-17

Publications (3)

Publication Number Publication Date
DK335686D0 DK335686D0 (da) 1986-07-15
DK335686A true DK335686A (da) 1987-02-25
DK173456B1 DK173456B1 (da) 2000-11-27

Family

ID=25041514

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198603356A DK173456B1 (da) 1985-07-17 1986-07-15 Fremgangsmåde til fremstilling af cis-enantiomere af 1-carba-3-cephem-4-carboxylsyrer og derivater deraf samt forskellige 3
DK016096A DK16096A (da) 1985-07-17 1996-02-15 Fremgangsmåde til fremstilling af ciaenantiomere af 1-carba-3-cephem-4-carboxylsyrer og derivater deraf samt N-alkylerede 3beta-beskyttet amino-azetidin-2-on-4beta-propansyre-thioestere, der er mellemprodukter ved fremgangsmåden

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK016096A DK16096A (da) 1985-07-17 1996-02-15 Fremgangsmåde til fremstilling af ciaenantiomere af 1-carba-3-cephem-4-carboxylsyrer og derivater deraf samt N-alkylerede 3beta-beskyttet amino-azetidin-2-on-4beta-propansyre-thioestere, der er mellemprodukter ved fremgangsmåden

Country Status (22)

Country Link
US (1) US4665171A (da)
EP (2) EP0362902B1 (da)
JP (2) JPH0762015B2 (da)
KR (1) KR900005257B1 (da)
CN (1) CN1015178B (da)
AR (1) AR243186A1 (da)
AT (2) ATE133172T1 (da)
AU (2) AU595216B2 (da)
CA (1) CA1310323C (da)
DE (2) DE3650474T2 (da)
DK (2) DK173456B1 (da)
ES (2) ES2000516A6 (da)
GR (1) GR861857B (da)
HK (1) HK1007140A1 (da)
HU (2) HU201931B (da)
IE (1) IE58997B1 (da)
IL (1) IL79420A (da)
NZ (1) NZ216871A (da)
PT (1) PT82989B (da)
RU (1) RU1794079C (da)
SU (1) SU1579460A3 (da)
ZA (1) ZA865274B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870169A (en) * 1985-07-17 1989-09-26 President And Fellows Of Harvard College Intermediates for beta-lactam antibiotics
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
US4734498A (en) * 1986-07-10 1988-03-29 Eli Lilly And Company 3β-succinimidoazetidinones as chiral intermediates
CA1323370C (en) * 1986-09-12 1993-10-19 Davis H. Crater Fluorochemical oxazolidinones
US4782144A (en) * 1987-09-14 1988-11-01 Eli Lilly And Company 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof
US5019571A (en) * 1988-01-25 1991-05-28 Eli Lilly And Company 1-carbacephalosporin antibiotics
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
US4855418A (en) 1988-03-23 1989-08-08 Eli Lilly And Company Process for production of ceophalosporins
JPH0225463A (ja) * 1988-06-06 1990-01-26 Eli Lilly & Co １―カルバ（１―デチア）―３―セフェム―４―カルボン酸の中間体の製造法
US4885362A (en) * 1988-06-06 1989-12-05 Eli Lilly And Company Azetidinone intermediates for 1-carba(dethia)caphalosporins
EP0345998A1 (en) * 1988-06-06 1989-12-13 Eli Lilly And Company Process and intermediates for beta-lactam antibiotics
ES2063129T3 (es) * 1988-06-22 1995-01-01 Lilly Co Eli Intermedio de la 1-carba(detia)cefalosporina.
KR0169096B1 (ko) * 1988-10-11 1999-01-15 리로이 휘테커 카바세팔로스포린의 아제티디논 중간체 화합물 및 제조방법
US5453503A (en) * 1988-10-11 1995-09-26 Eli Lilly And Company Azetidinone intermediates to carbacephalosporins and process
US4931556A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-methoxycarbonylmethyl-azetidin-2-one and malic acid salts thereof
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
JPH02252648A (ja) * 1989-03-27 1990-10-11 Naomi Iwagou イオン溶出燒結体
US5106475A (en) * 1989-09-20 1992-04-21 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US4992545A (en) * 1989-09-20 1991-02-12 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US5030725A (en) * 1990-02-06 1991-07-09 Eli Lilly And Company Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using (-)-DAG
US5051502A (en) * 1990-06-06 1991-09-24 University Of Notre Dame Du Lac Rhodium catalyzed cyclization process for bicyclic β-lactams
DK0479431T3 (da) * 1990-09-13 2000-03-27 Lilly Co Eli Mellemprodukter for 1-carbacephalosporiner og fremgangsmåde til fremstilling heraf
US5089610A (en) * 1991-04-25 1992-02-18 Eli Lilly And Company Ring-closure method for 1-carbacephalosporin six-membered ring
US5521307A (en) * 1992-02-18 1996-05-28 Eli Lilly And Company Methods and compounds for the preparation of carbacephems
DE69734321T2 (de) 1996-02-23 2006-08-10 Eli Lilly And Co., Indianapolis Non-peptidische vasopressin via antagonisten
JP2002535680A (ja) 1999-01-27 2002-10-22 ファルマシア・アンド・アップジョン・カンパニー 延長因子ｐ活性モジュレーターのアッセイ方法
JP4916929B2 (ja) * 2007-03-23 2012-04-18 ヤマハ発動機株式会社 直交型ロボット
NZ583970A (en) 2007-10-11 2011-04-29 Univ California Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase
US9376424B2 (en) 2010-07-01 2016-06-28 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
WO2014144547A2 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
WO2014144836A2 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
US9802925B2 (en) 2014-03-28 2017-10-31 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
WO2017221144A1 (en) * 2016-06-20 2017-12-28 Dr. Reddy's Laboratories Limited Process for the preparation of elagolix sodium and its polymorph
CN112500361B (zh) * 2020-12-27 2023-05-12 甘肃瀚聚药业有限公司 一种(s)-4-苯基-2-恶唑烷酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
US4200572A (en) * 1975-09-03 1980-04-29 Smithkline Corporation Substituted azetidinones
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one
US4472576A (en) * 1982-12-03 1984-09-18 Merck & Co., Inc. Processes for the production of antibiotic 1-oxadethiacephalosporins
US4502994A (en) 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
US4673737A (en) 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
JP2634775B2 (ja) 1997-07-30
DE3650474D1 (de) 1996-02-29
IE58997B1 (en) 1993-12-15
DE3679002D1 (de) 1991-06-06
IE861900L (en) 1987-01-17
AU619938B2 (en) 1992-02-06
ZA865274B (en) 1988-02-24
KR900005257B1 (ko) 1990-07-21
JPH07300476A (ja) 1995-11-14
JPH0762015B2 (ja) 1995-07-05
CA1310323C (en) 1992-11-17
IL79420A (en) 1992-01-15
ATE63118T1 (de) 1991-05-15
ES2000516A6 (es) 1988-03-01
HU906465D0 (en) 1991-04-29
HK1007140A1 (en) 1999-04-01
CN1015178B (zh) 1991-12-25
DK173456B1 (da) 2000-11-27
US4665171A (en) 1987-05-12
PT82989A (en) 1986-08-01
EP0362902A3 (en) 1990-08-01
AU6016686A (en) 1987-01-22
EP0209352A2 (en) 1987-01-21
GR861857B (en) 1986-11-18
EP0209352A3 (en) 1988-04-20
EP0362902B1 (en) 1996-01-17
EP0362902A2 (en) 1990-04-11
ES2005752A6 (es) 1989-03-16
KR870001193A (ko) 1987-03-12
CN86104783A (zh) 1987-02-04
NZ216871A (en) 1989-10-27
ATE133172T1 (de) 1996-02-15
AR243186A1 (es) 1993-07-30
RU1794079C (ru) 1993-02-07
JPS6242985A (ja) 1987-02-24
EP0209352B1 (en) 1991-05-02
AU595216B2 (en) 1990-03-29
DE3650474T2 (de) 1996-06-13
HUT41786A (en) 1987-05-28
DK335686D0 (da) 1986-07-15
AU4793490A (en) 1990-05-10
SU1579460A3 (ru) 1990-07-15
DK16096A (da) 1996-02-15
PT82989B (pt) 1989-01-30
HU201931B (en) 1991-01-28

Similar Documents

Publication Publication Date Title
DK335686D0 (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
NO862773D0 (no) Fremgangsmaate ved fremstilling av fenyletanolaminotetraliner med lipolytisk aktivitet.
DK214687D0 (da) Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf
DK534286D0 (da) Nicotinsyrederivater, deres fremstilling og anvendelse som herbicider samt mellemprodukter ved fremstillingen og disses fremstilling
NO863574D0 (no) Fremgangsmaate ved fremstilling av tetrafluorbenzosyre.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
DK165728C (da) Fremgangsmaade til fremstilling af individuelt doserede indgivelsesportioner, samt ved fremgangsmaaden fremstillede indgivelsesportioner
DK504580A (da) Fremgangsmaade til fremstilling af benzodiazepinderivater eller farmaceutisk acceptable syreadditionssalte deraf samt ved fremgangsmaaden anvendelige mellemprodukter
NO860794L (no) Fremgangsmaate ved fremstilling av klordioksyd.
DK177489A (da) Cholestadienderivater som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater
DK223783A (da) Fremgangsmaade til fremstilling af dihydropyridiner samt mellemprodukter til anvendelse ved fremgangsmaaden
NO864525D0 (no) Fremgangsmaate ved fremstilling av aryleddiksyrederivater.
DK56490A (da) Homocholestenderivater som mellemprodukter til brug ved fremstillingen af 26-homovitamin d3 derivater
NO861239L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
DK145685D0 (da) Fremgangsmaade til fremstilling af 4-acetylimidazolderivater samt mellemprodukter til brug ved fremgangsmaaden
DK204891D0 (da) Hidtil ukendte cyanoalkylbenzamidderivater, fremgangsmaade til fremstilling deraf, samt anvendelse af saadanne cyanoalkylbenzamidderivater som mellemprodukt ved fremstilling af substituerede n-(imidazolinyl-methyl)-benzamider
DK559786A (da) Mellemprodukter til fremstilling af beta-lactamantibiotika
DK158347C (da) Analogifremgangsmaade til fremstilling af 1-acyl-2,3-dihydro-1h-indol-2-carboxylsyrer eller derivater deraf samt mellemprodukter til brug ved fremgangsmaaden
DK98086D0 (da) Fremgangsmaade og mellemprodukter til fremstilling af 2-cyanamino-1,3,5-triaziner samt mellemprodukternes fremstilling
NO166082C (no) Mellomprodukter til bruk ved fremstilling av imidazokinolinonderivater.
DK87285A (da) Fremgangsmaade til fremstilling af 3-methyl-7-fluor-5-nitrobenzothiophen samt ved fremstillingen benyttes mellemprodukter
DK476985D0 (da) Fremgangsmaade til fremstilling af oxadiazolylderivater af imidazobenzodiazepiner og mellemprodukt til brug ved fremgangsmaaden
DK220385D0 (da) Fremgangsmaade til fremstilling af oxadiazolylderivater af imidazobenzodiazepiner og mellemprodukt til brug ved fremgangsmaaden

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired